Business Description
Vivo Bio Tech Ltd
ISIN : INE380K01017
Total Employee Number:
174Compare
Compare
Traded in other countries / regions
511509.India IPO Date
2017-03-03Description
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 3.17 | |||||
Interest Coverage | 1.85 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.88 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.1 | |||||
3-Year EBITDA Growth Rate | -11 | |||||
3-Year Book Growth Rate | 6.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 83.24 | |||||
9-Day RSI | 69.15 | |||||
14-Day RSI | 59.56 | |||||
3-1 Month Momentum % | -9.27 | |||||
6-1 Month Momentum % | -24.42 | |||||
12-1 Month Momentum % | -34.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 342.44 | |||||
Days Sales Outstanding | 84.79 | |||||
Days Payable | 68.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.2 | |||||
Shareholder Yield % | -41.08 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.76 | |||||
Operating Margin % | 20.29 | |||||
Net Margin % | -3.2 | |||||
EBITDA Margin % | 39.91 | |||||
FCF Margin % | -4.7 | |||||
OCF Margin % | 65.49 | |||||
ROE % | -1.91 | |||||
ROA % | -1.05 | |||||
ROC (Joel Greenblatt) % | 11.62 | |||||
ROCE % | 7.99 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 7.88 | |||||
Price-to-Owner-Earnings | 16.21 | |||||
PS Ratio | 0.94 | |||||
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 1.33 | |||||
Price-to-Operating-Cash-Flow | 1.5 | |||||
EV-to-EBIT | 11.43 | |||||
EV-to-EBITDA | 5.72 | |||||
EV-to-Revenue | 2.28 | |||||
EV-to-FCF | -48.61 | |||||
Price-to-GF-Value | 0.86 | |||||
Price-to-Projected-FCF | 2.49 | |||||
Earnings Yield (Greenblatt) % | 8.75 | |||||
FCF Yield % | -4.48 | |||||
Forward Rate of Return (Yacktman) % | -18.36 |
Vivo Bio Tech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivo Bio Tech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vivo Bio Tech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers